The individual performance of each of the blood biomarkers, age and BC parameters for categorizing the tumors as ‘high’, ‘intermediate’ or ‘low’ in terms of sTILs, CD3 or CD8 infiltration can be found in Tables S3–S7. This evidence concerns the gene CD8A and breast cancer.